MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torrecillas, G.
Right arrow Articles by Rodríguez-Puyol, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torrecillas, G.
Right arrow Articles by Rodríguez-Puyol, D.

Vol. 59, Issue 1, 104-112, January 2001

The Role of Hydrogen Peroxide in the Contractile Response to Angiotensin II

Guadalupe Torrecillas, Maria del Carmen Boyano-Adánez, J. Medina, Trinidad Parra, Mercedes Griera, Susana López-Ongil, Eduardo Arilla, Manuel Rodríguez-Puyol, and Diego Rodríguez-Puyol

Departments of Physiology (G.T., M.G., S.L.-O., M.R.-P.), Biochemistry (M.d.C.B.-A., E.A.), and Medicine (D.R.-P.), Alcalá University; Nephrology Section, Hospital Príncipe de Asturias (D.R.-P.), and Instituto Reina Sofía de Asturias (D.R.-P.), and Instituto Reina Sofía de Investigaciones Nefrológicas, Madrid, Spain; Novartis Pharma Laboratories, Basel, Switzerland (J.M.); and Research Unit, Hospital de Guadalajara, Spain (T.P.)

In the last years, reactive oxygen species (ROS) have been proposed as mediators of proliferative/hypertrophic responses to angiotensin II (Ang II), both in vivo and in vitro. However, the hypothesis that the Ang II-dependent cell contraction could be mediated by ROS, particularly H2O2, has not been tested. Present experiments were devoted to test this hypothesis and to analyze the possible mechanisms involved. Catalase (CAT) prevented the increased myosin light chain phosphorylation and the decreased planar cell surface area (PCSA) induced by 1 µM Ang II in cultured rat vascular smooth muscle cells (VSMC). This preventive effect of CAT was also detected when 1 µM platelet-activating factor (PAF) was used as a contractile agonist instead of Ang II. Similar results were found when using horseradish peroxidase as an H2O2 scavenger or cultured rat mesangial cells. In vascular smooth muscle cells, CAT modified neither the binding of labeled Ang II nor the Ang II-induced inositol 1,4,5-trisphosphate (IP3) synthesis. However, it completely abolished the Ang II-dependent calcium peak, in a dose-dependent fashion. CAT-loaded cells (increased intracellular CAT concentration over 3-fold) did not show either a decreased PCSA or an increased intracellular calcium concentration after Ang II treatment. Ang II stimulated the H2O2 synthesis by cultured cells, and the presence of CAT in the extracellular compartment significantly diminished the Ang II-dependent increased intracellular H2O2 concentration. The physiological importance of these findings was tested in rat thoracic aortic rings: CAT prevented the contraction elicited by Ang II. In summary, present experiments point to H2O2 as a critical intracellular metabolite in the regulation of cell contraction.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Szasz, J. M. Thompson, and S. W. Watts
A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1341 - H1350.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Ding, A. Zhang, S. Huang, X. Pan, G. Zhen, R. Chen, and T. Yang
ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1889 - F1897.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
A. N. Lyle and K. K. Griendling
Modulation of vascular smooth muscle signaling by reactive oxygen species.
Physiology, August 1, 2006; 21: 269 - 280.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Perez-Rivero, M. P. Ruiz-Torres, J. V. Rivas-Elena, M. Jerkic, M. L. Diez-Marques, J. M. Lopez-Novoa, M. A. Blasco, and D. Rodriguez-Puyol
Mice Deficient in Telomerase Activity Develop Hypertension Because of an Excess of Endothelin Production
Circulation, July 25, 2006; 114(4): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. M. Paravicini and R. M. Touyz
Redox signaling in hypertension
Cardiovasc Res, July 15, 2006; 71(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. De Frutos, M. Saura, M. Griera, F. J. Rivero-Vilches, C. Zaragoza, D. Rodriguez-Puyol, and M. Rodriguez-Puyol
Differential Regulation of Soluble Guanylyl Cyclase Expression and Signaling by Collagens: Involvement of Integrin-Linked Kinase
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2626 - 2635.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Kimura, G.-X. Zhang, A. Nishiyama, T. Shokoji, L. Yao, Y.-Y. Fan, M. Rahman, and Y. Abe
Mitochondria-Derived Reactive Oxygen Species and Vascular MAP Kinases: Comparison of Angiotensin II and Diazoxide
Hypertension, March 1, 2005; 45(3): 438 - 444.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P.-T. Brinkkoetter, S. Holtgrefe, F. J. van der Woude, and B. A. Yard
Angiotensin II Type 1-Receptor Mediated Changes in Heparan Sulfate Proteoglycans in Human SV40 Transformed Podocytes
J. Am. Soc. Nephrol., January 1, 2004; 15(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Taniyama and K. K. Griendling
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Hypertension, December 1, 2003; 42(6): 1075 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. J. Rivero-Vilches, S De Frutos, M Saura, D Rodriguez-Puyol, and M Rodriguez-Puyol
Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I{alpha} activation by NO/cGMP
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C891 - C898.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. GORIN, N.-H. KIM, D. FELIERS, B. BHANDARI, G. G. CHOUDHURY, and H. E. ABBOUD
Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase
FASEB J, September 1, 2001; 15(11): 1909 - 1920.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics